SCHEMBL8812669

SCHEMBL8812669

CCO[PH](=O)Cc1ccc(OCc2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.53
L3MBTL1 Q9Y468 3/20 0.51
GAA P10253 1/20 0.51
MAPT P10636 1/20 0.51
MAOA P21397 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ALOX5 P09917 2/20 0.51
BCHE P06276 1/20 0.49
LMNA P02545 2/20 0.49
CYP1A2 P05177 1/20 0.49
PTGS1 P23219 1/20 0.49
SLC6A2 P23975 1/20 0.49
CYP2C19 P33261 1/20 0.49
PTGS2 P35354 1/20 0.49
SLC6A3 Q01959 1/20 0.49
HIF1A Q16665 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
AR P10275 1/20 0.48
FFAR1 O14842 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL563886 0.85 TP53 (0.41) MAOBSMN1; SMN2
SCHEMBL11609893 0.77 IDO1 (0.48) MAOBSMN1; SMN2
SCHEMBL29255542 0.77 MAOB (0.61) MAOBL3MBTL1GAAMAPTMAOA
SCHEMBL969878 0.76 TSHR (0.46) MAOBL3MBTL1GAAMAPTMAOA
SCHEMBL11293541 0.76 LMNA (0.67) MAOBL3MBTL1GAAMAPTMAOA
Butane SCHEMBL8010999 0.76 PTGS1 (0.53) MAOBL3MBTL1GAAMAPTMAOA
SCHEMBL8814962 0.75 ESR1 (0.40) L3MBTL1LMNAPTGS1SLC6A2CYP2C19
SCHEMBL464352 0.75 RXRA (0.66) MAOBL3MBTL1GAAMAPTMAOA
SCHEMBL19223062 0.75 LTA4H (0.67) MAOBL3MBTL1GAAMAPTMAOA
SCHEMBL10051635 0.75 TAAR1 (0.40) MAPTSMN1; SMN2LMNACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997011953-A1 NOVEL HYDROXYLATED AND ALKOXYLATED N- AND/OR P-ARALKYLPHOSPHINIC ACID DERIVATIVES NOVARTIS AG (CH) 1997-04-03 WO disclosed